Diffuse Lewy body disease

Internal Medicine

Volumn 37, Issue 1, 1998, Pages 6-10

  Kosaka, Kenji ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Dementia; Diffuse lewy body disease; Lewy body

Indexed keywords

RISPERIDONE; TACRINE;

ALZHEIMER DISEASE; CLINICAL FEATURE; DEGENERATIVE DISEASE; DEMENTIA; LEWY BODY; NEUROPATHOLOGY; PARKINSONISM; PSYCHOSIS; REVIEW;

EID: 0031907008     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.6     Document Type: Review

References (43)

1. Kosaka K. Lewy bodies in cerebral cortex. Report of three cases. Acta Neuropathol (Berl) 42: 127, 1978.
2. Kosaka K, Yoshimura M, Ikeda K, Budka H. Diffuse type of Lewy body disease. Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree-a new disease? Clin Neuropathol 3: 185, 1984.
3. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 237: 197, 1990.
4. Gibb WRG, Esiri MM, Lees AJ. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110: 1131, 1987.
5. Perry RH, Irving D, Blessed G, et al. Senile dementia of Lewy body type. A clinically and neuropathologically distinct type of Lewy body dementia in the elderly. J Neurol Sci 95: 119, 1990.
6. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: A clinical and pathological entity. Neurology 40: 1, 1990.
7. Kosaka K, Iseki E. Diffuse Lewy body disease within the spectrum of Lewy body disease, in: Dementia with Lewy bodies. Perry R, McKeith I, Perry E, Eds. Cambridge University Press, Cambridge, 1996, p. 238.
8. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47: 1113, 1996.
9. Perry R, McKeith IG, Perry E. Dementia with Lewy Bodies. Clinical, Pathological, Treatment Issues. Cambridge University Press, Cambridge, 1996.
10. Dickson DW, Crystal H, Mattiace LA, et al. Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol (Berl) 78: 572, 1989.
11. Burns A, Luthert P, Levy R, et al. Accuracy of clinical diagnosis of Alzheimer's disease. Brit Med J 301: 1026, 1990.
12. Galasko D, Hansen LA, Katzman R, et al. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 51: 888, 1994.
13. Ince PG, McArthur FK, Bjertness E, et al. Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions. Dementia 6: 162, 1995.
14. Kosaka K, Mark MH, Sage JI. Diffuse Lewy body disease, in: Practical Neurology of the Elderly. Sage JI and Mark MH, Eds. Marcel Dekker, New York, Basel, Hong Kong, 1996, p. 697.
15. McKeith IC, Galasko D, Wilcock GK, et al. Lewy body dementia. Diagnosis and treatment. Brit J Psychiatry 167: 709, 1995.
16. Louis ED, Goldman JE, Powers JM, et al. Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease. Mov Disord 10: 188, 1995.
17. Sahgal A, McKeith IG, Galloway PH, et al. Do differences in visuospatial ability between senile dementia of the Alzheimer and Lewy body types reflect differences solely in mnemonic function? J Clin Exp Neuropsychol 17: 35, 1995.
18. Iseki E, Odawara T, Suzuki K, et al. A pathological study of Lewy bodies and senile changes in the amygdala in diffuse Lewy body disease. Neuropathology 15: 112, 1995.
19. Kosaka K, Oyanagi S, Matsushita M, et al. Presenile dementia with Alzheimer-, Pick- and Lewy-body changes. Acta Neuropathol (Berl) 36: 221, 1976.
20. Odawara T, Iseki E, Kosaka K, et al. Incidence and distribution of senile plaques and neurofibrillary tangles in late-onset diffuse Lewy body disease. Neuropathology 14: 7, 1994.
21. Wakabayashi K, Hansen LA, Masliah E. Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32. Acta Neuropathol (Berl) 89: 404, 1995.
22. Smith MC, Mallory M, Hansen LA, et al. Fragmentation of the neuronal cytoskeleton in the Lewy body variant of Alzheimer's disease. Neuroreport 6: 673, 1995.
23. Nishiyama K, Murayama S, Shimizu J, et al. Cu/Zn superoxide dismutase-like immunoreactivity is present in Lewy bodies from Parkinson disease: a light and electron microscopic immunocytochemical study. Acta Neuropathol (Berl) 89: 471, 1995.
24. 2-3 neurites specific to DLBD. Neurology 41: 1402, 1991.
25. Kim H, Gearing M, Mirra SS. Ubiquitin-positive CA2/3 neurites in hippocampus coexist with cortical Lewy bodies. Neurology 45: 1768, 1995.
26. Hansen L, Masliah E, Terry RD, et al. A neuropathological subunit of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol (Berl) 78: 194, 1989.
27. Iseki E, Li F, Kosaka K. Close relationship between spongiform change and ubiquitin-positive granular structures in diffuse Lewy body disease. J Neurol Sci 146: 53, 1997.
28. Kosaka K, Iseki E, Odawara T, et al. "Cerebral type of Lewy body disease"- A case report. Neuropathology 16: 72, 1996.
29. Perry EK, Morris CM, Court JA, et al. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience 64: 385, 1995.
30. Mantle D, Falkous G, Ishiura S, et al. Comparison of cathepsin protease activities in brain tissue from normal cases and with Alzheimer's disease. Lewy body dementia, Parkinson's disease and Huntington's disease. J Neurol Sci 131: 65, 1995.
31. Scott HL, Tannenberg AE, Dodd PR. Variant forms of neuronal glutamate transporter sites in Alzheimer's disease cerebral cortex. J Neurochem 64: 2193, 1995.
32. Lippa CF, Smith TW, Saunders AM, et al. Apolipoprotein E genotype and Lewy body disease. Neurology 45: 97, 1995.
33. Kawanishi C, Suzuki K, Odawara T, et al. Neuropathological evaluation and apolipoprotein E gene polymorphism analysis in diffuse Lewy body disease. J Neurol Sci 136: 140, 1996.
34. Saitoh T, Xia Y, Chen X, et al. The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease. Ann Neurol 37: 110, 1995.
35. Chagnon P, Betard C, Robitaille Y, et al. Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. Neuroreport 6: 711, 1995.
36. de la Monte SM, Ng SC, Hsu DW. Aberrant GAP-43 gene expression in Alzheimer's disease. Am J Pathol 147: 934, 1995.
37. Iwatsubo T, Yamaguchi H, Fujimuro M, et al. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am J Pathol 148: 1517, 1996.
38. Spillantini MG, Schmidt ML, Lee VML, et al. α-synuclein in Lewy bodies. Nature 388: 839, 1997.
39. Allen RL, Walker Z, O'Ath PJ, et al. Risperidone for psychotic and behavioural symptoms in Lewy body dementia. Lancet 346: 185, 1995 (letter).
40. McKeith IG, Ballard CG, Harrison RW. Neuroleptic sensitivity to risperidone in Lewy body dementia. Lancet 346: 699, 1995 (letter).
41. Perry EK, Haroutunian V, Davis KL, et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport 5: 747, 1994.
42. Levy R, Eagger S, Griffiths M, et al. Lewy bodies and response to tacrine in Alzheimer's disease. Lancet 343: 176, 1994 (letter).
43. Liberini P, Memo M, Spano P. Lewy body pathology and heterogeneity of Alzheimer's disease. JAMA 274: 1199, 1995 (letter).